About PharmaLex
PharmaLex is a company based in Mannheim (Germany) founded in 1998 was acquired by AmerisourceBergen in September 2022. The company has 267 employees as of April 08, 2024. PharmaLex has completed 6 acquisitions, including Arbour Group, DRA and ERA Consulting. PharmaLex offers products and services including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC. PharmaLex operates in a competitive market with competitors including ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.
- Headquarter Mannheim, Germany
- Employees 267 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmalex India Private Limited
- Date of Incorporation 23 May, 2013
- Jurisdiction Delhi, India
-
Annual Revenue
$7.47 M (USD)10.24as on Mar 31, 2023
-
Net Profit
$814.77 K (USD)-39.79as on Mar 31, 2023
-
EBITDA
$1.1 M (USD)-47.46as on Mar 31, 2023
-
Latest Funding Round
$38.44 K (USD), Grant
Jun 01, 2022
-
Investors
AmerisourceBergen
& 2 more
-
Employee Count
267
as on Apr 08, 2024
-
Investments & Acquisitions
Arbour Group
& 5 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PharmaLex
PharmaLex offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.
Provides strategic advice for pharmaceutical and biotech development.
Offers end-to-end solutions for product innovation and market access.
Manages compliance and regulatory writing for industry standards.
People of PharmaLex
Unlock access to complete
Funding Insights of PharmaLex
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $38,445
-
First Round
First Round
(01 Jan 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Grant - PharmaLex | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - PharmaLex | Valuation |
investors |
Investors in PharmaLex
PharmaLex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include AmerisourceBergen and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Pharmaceutical distribution and supply chain services are provided globally.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PharmaLex
PharmaLex has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arbour Group, DRA and ERA Consulting.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Market access services are provided to the biopharma sector.
|
2002 | ||||
|
Natural gas is transported via pipelines from production to markets.
|
2002 | ||||
|
Regulatory compliance services are provided to businesses since 1995.
|
1995 |
Financial Statements - PharmaLex
Pharmalex Comparisons
Competitors of PharmaLex
PharmaLex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
|
|
| domain | founded_year | HQ Location |
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
|
|
| domain | founded_year | HQ Location |
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
|
|
| domain | founded_year | HQ Location |
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
|
|
| domain | founded_year | HQ Location |
Provider of regulatory compliance and validation support to life science industries
|
Frequently Asked Questions about PharmaLex
PharmaLex was founded in 1998 and raised its 1st funding round 21 years after it was founded.
PharmaLex is headquartered in Mannheim, Germany. It is registered at Mannheim, Baden-wurttemberg, Germany.
As of Apr 08, 2024, the latest employee count at PharmaLex is 267.
Annual revenue of PharmaLex is $7.47M as on Mar 31, 2023.
PharmaLex was founded in 1998 and operates as a contract research organization in the pharmaceutical sector from Mannheim, Germany. The current entity was established in 2015 through the merger of YES Pharma and PharmaLex. Services encompass development consulting, scientific affairs including clinical trial design and CTD documents, regulatory affairs such as procedure management and electronic submissions, and pharmacovigilance covering risk management, signal detection, and ICSR processing.
PharmaLex's top competitors include ProPharma Group, Pharma-Bio Serv and Validant.
PharmaLex offers Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.
PharmaLex has made 6 acquisitions, including Arbour Group, DRA, and ERA Consulting.
PharmaLex has 2 investors. Key investors include AmerisourceBergen, and European Union.